An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.
In this Product Explainer, Sexual Health Physician Dr Terri Foran explains estradiol and progesterone combined hormone therapy, the first and only body-identical combined treatment for post-menopausal women (6 mins).
No longer is it okay to just monitor a patient with mild hyperparathyroidism as research shows the untreated condition is associated with a significantly increased risk of cardiovascular death
Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA
Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.